Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, PR China.
Department of Cardiovascular Disease, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong 518033, PR China.
Life Sci. 2024 Oct 15;355:122998. doi: 10.1016/j.lfs.2024.122998. Epub 2024 Aug 20.
Myocardial ischemia-reperfusion injury (MIRI) is an injury to cardiomyocytes due to restoration of blood flow after myocardial infarction (MI). It has recently gained much attention in clinical research with special emphasis on the roles of mitochondrial autophagy and inflammation. A mild inflammatory response promotes recovery of post-ischemic cardiomyocyte function and vascular regeneration, but a severe inflammatory response can cause irreversible and substantial cellular damage. Similarly, moderate mitochondrial autophagy can help inhibit excessive inflammation and protect cardiomyocytes. However, MIRI is aggravated when mitochondrial function is disrupted, such as inadequate clearance of damaged mitochondria or excessive activation of mitophagy. How to moderately control mitochondrial autophagy while promoting its balance with nucleotide-binding oligomerization structural domain receptor protein 3 (NLRP3) inflammasome activation is critical. In this paper, we reviewed the molecular mechanisms of mitochondrial autophagy and NLRP3 inflammasome, described the interaction between NLRP3 inflammasome and mitochondrial autophagy, and the effects of different signaling pathways and molecular proteins on MIRI, to provide a reference for future research.
心肌缺血再灌注损伤(MIRI)是心肌梗死后血流恢复导致的心肌细胞损伤。它最近在临床研究中受到了广泛关注,特别强调了线粒体自噬和炎症的作用。轻度炎症反应促进缺血后心肌细胞功能和血管再生的恢复,但严重的炎症反应会导致不可逆转的实质性细胞损伤。同样,适度的线粒体自噬有助于抑制过度炎症并保护心肌细胞。然而,当线粒体功能受到破坏时,MIRI 会加重,例如受损线粒体的清除不足或线粒体自噬的过度激活。如何适度控制线粒体自噬,同时促进其与核苷酸结合寡聚化结构域受体蛋白 3(NLRP3)炎性小体激活的平衡,是至关重要的。本文综述了线粒体自噬和 NLRP3 炎性小体的分子机制,描述了 NLRP3 炎性小体与线粒体自噬的相互作用,以及不同信号通路和分子蛋白对 MIRI 的影响,为未来的研究提供参考。